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ORIGINAL ARTICLE Open Access
Using body mass index to estimate
individualised patient radiation dose in
abdominal computed tomography
Siobhan O’Neill1,2, Richard G. Kavanagh1,2* , Brian W. Carey2, Niamh Moore1, Michael Maher1,2,3
and Owen J. O’Connor1,2,3
Abstract
Background: The size-specific dose estimate (SSDE) is a dose-related metrics that incorporates patient size into its
calculation. It is usually derived from the volume computed tomography dose index (CTDIvol) by applying a
conversion factor determined from manually measured anteroposterior and lateral skin-to-skin patient diameters at the
midslice level on computed tomography (CT) localiser images, an awkward, time-consuming, and not highly reproducible
technique. The objective of this study was to evaluate the potential for the use of body mass index (BMI) as a size-related
metrics alternative to the midslice effective diameter (DE) to obtain a size-specific dose (SSDE) in abdominal CT.
Methods: In this retrospective study of patients who underwent abdominal CT for the investigation of inflammatory
bowel disease, the DE was measured on the midslice level on CT-localiser images of each patient. This was
correlated with patient BMI and the linear regression equation relating the quantities was calculated. The ratio
between the internal and the external abdominal diameters (DRATIO) was also measured to assess correlation
with radiation dose. Pearson correlation analysis and linear regression models were used.
Results: There was good correlation between DE and patient BMI (r = 0.88). An equation allowing calculation
of DE from BMI was calculated by linear regression analysis as follows: DE = 0.76 (BMI) + 9.4. A weak correlation
between radiation dose and DRATIO was demonstrated (r = 0.45).
Conclusions: Patient BMI can be used to accurately estimate DE, obviating the need to measure anteroposterior and
lateral diameters in order to calculate a SSDE for abdominal CT.
Keywords: Abdomen, Body mass index, Tomography (x-ray, computed), Radiation dosage
Key points
 A strong correlation between BMI and DE was found
 BMI can be used to estimate patient DE
 Calculating patient BMI can facilitate individualised
patient radiation dose estimation in abdominal CT
Background
The individual patient radiation dose from computed
tomography (CT) is notoriously difficult to estimate.
There is a growing interest in this topic, however, due to
the ever-increasing CT use and general concerns about
the risks associated with radiation exposure from med-
ical imaging. This has precipitated the increased use of
dose monitoring systems in clinical practice.
Current CT scanner radiation dose output following
patient imaging is displayed in the CT dose report in
terms of volume CT dose index (CTDIvol) and dose
length product (DLP), standardised measurements de-
duced from homogenous phantoms under normalised
conditions [1, 2]. These parameters do not provide a dir-
ect measure of the individualised patient radiation dose,
a variable that is dependent on patient size.
The size-specific dose estimate (SSDE) is a dose-related
metrics that incorporates patient size into its calculation.
This metric has been advocated for the reporting of
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patient radiation dose in CT by the American Association
of Physicists in Medicine (AAPM) task group 204 and has
increasingly been applied and accepted [3, 4]. The SSDE is
derived from the CTDIvol by applying a conversion factor
determined from manually measured anteroposterior and
lateral skin-to-skin patient diameters at the midslice level
on CT-localiser images [3]. On a practical level this tech-
nique can be awkward and time-consuming, and open to
interobserver measurement variability.
The objective of this study was to evaluate the poten-
tial for using body mass index (BMI) as an alternative
size metrics, in lieu of measured body diameters, to esti-
mate patient effective diameter (DE). Thus, estimation of
SSDE at the time of CT scanning would be more
user-friendly, contributing positively to patient radiation
dose optimisation.
Methods
Subjects
This study was performed retrospectively on CT data ac-
quired as part of a clinical trial protocol investigating the
use of CT in inflammatory bowel disease (ClinicalTrials.
gov Identifier: NCT 01244386) [5] with approval from
the institution Clinical Research Ethics Committee. Fifty
adult patients were included in this study and, as part of
this trial protocol, all patients signed informed consent.
CT scan protocol
All patients underwent a CT scan of the abdomen and
pelvis with a standardised protocol using the following
parameters: scan range encompassing the lung bases to
the pubic symphysis; 0.625-mm slice acquisition thickness;
intravenously administered contrast (Iohexol, Omnipaque
300, General Electric Healthcare, Waukesha, WI, USA)
delivered at 2.5 mL/s and imaged in the portal venous
phase; 1.5 L of positive oral contrast (2% Gastrografin,
Bracco Diagnostics Inc., Princeton, NJ, USA); tube voltage
of 120 kVp; automated tube current modulation resulting
in a variable current with a minimum of 50 mA and a
maximum of 350 mA; gantry rotation time of 0.8 s; noise
index 38. All CT images were acquired using a single
64-slice multi-detector row CT scanner (Lightspeed
VCT-XTe, GE Healthcare, General Electric Medical Sys-
tems, Waukesha, WI, USA). The DLP and CTDIvol values,
as well as the corresponding phantom size, were recorded
from each CT dose report. CTDIvol and DLP tolerances
were verified using a standard 32-cm Perspex phantom, a
10-cm ionisation chamber with a Victoreen NERO mAx
unit (Fluke Biomedical, Solon, OH, USA).
The SSDEs were calculated by multiplying the CTDIvol
of each patient by conversion factors corresponding to the
effective patient diameters in the AAPM reference tables
[3]. The imaging performance and assessment from CT
patient dosimetry calculator (ImPACT version 0.99x,
London, UK) was used to calculate the effective dose.
BMI measurement
Each patient had weight and height measurements per-
formed and their BMI calculated immediately prior to
CT scan using a dedicated calibrated measuring device
(electronic measuring station Model 763, Seca Medical,
Hamburg, Germany). BMI data were used to subdivide
patient groups, where underweight referred to BMI <
18.5 kg/m2, normal weight referred to 18.5 ≤ BMI <
25 kg/m2, overweight referred to 25 ≤ BMI < 30 kg/m2
and obese referred to BMI ≥ 30 kg/m2.
Body diameter measurements
Images were reviewed on a picture-archiving and com-
munication system (PACS) workstation (Impax 6.3.1,
Fig. 1 Measurement of lateral (DLAT) (a) anteroposterior (DAP) (b) skin-to-skin patient diameters at the midslice level on CT-localiser images.
Measurement of the inner lateral and anteroposterior diameters on the axial midslice CT image excluding the subcutaneous adipose tissue (c)
to allow calculation of the effect inner diameter (DIN) and the effective diameter ratio (DRATIO)
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AGFA Healthcare, Morstel, Belgium) in a DICOM format.
As per AAPM Report 204 guidelines, body diameters were
measured at the midslice level (median image of the cra-
niocaudal scanning length) on the CT-localiser images be-
cause, for larger patients, maximum skin-to-skin distance
is often not included on transverse CT images [3, 6].
Diameter measurements were performed manually with
the electronic callipers available on the PACS using a win-
dow width of 350 Hounsfield Units (HU) and window
level of 50 HU. From personal experience at our institu-
tion, analysis of interoperator variability for PACS-based
anthropometric measurements shows no statistically sig-
nificant differences. Therefore, a single investigator carried
out all measurements. A fixed window level and setting
was used for each individual study.
Maximum skin-to-skin anteroposterior diameter (DAP)
and lateral diameter (DLAT) were measured in centi-
metres on lateral and anteroposterior localiser images,
respectively. DAP is defined as the anteroposterior
skin-to-skin diameter on the lateral localiser at the
midslice level (Fig. 1a) while DLAT is defined as the
lateral skin-to-skin diameter on the anteroposterior
localiser image at the midslice level (Fig. 1b). The DE
is defined as the diameter of the circle with area
equivalent to the cross-sectional area of the patient at
the particular z-axis level (i.e. the midslice level) and
Table 1 Summary of mean values for computed tomography dose metrics, overall and stratified for body mass index (BMI)
All (n = 50) BMI < 25 kg/m2 (n = 32) BMI≥ 25 kg/m2 (n = 18) p-value
CTDIvol (mGy) 6.26 ± 3.83 4.33 ± 0.83 9.68 ± 4.65 0.000
a
DLP (mGy.cm) 299.42 ± 196.06 202.36 ± 41.27 471.96 ± 241.73 0.000a
SSDE (mGy) 7.81 ± 3.08 6.22 ± 0.75 10.64 ± 3.61 0.000a
Effective dose (mSv) 4.77 ± 3.23 3.18 ± 0.62 7.59 ± 1.64 0.000a
CTDIvol volume-computed tomography dose index, DLP dose length product, SSDE size-specific dose estimate, BMI Body mass index
Data as means ± standard deviations of the mean
aValue shows a statistically significant difference with a two-tailed p-value of less than 0.05, when the radiation doses of each protocol are compared with one another
Fig. 2 Graphs show the relationship of body mass index (BMI) to anteroposterior diameter (DAP) (a), lateral diameter (DLAT) (b), effective diameter
(DE) (c) and effective diameter ratio (DRATIO) (d). Correlation coefficients were 0.83, 0.84, 0.88, and 0.48, respectively (p < 0.001)
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Table 2 Summary of body mass index category and midslice diameter measurements
DAP (cm) DLAT (cm) DE (cm) DRATIO
Overall (n = 50) 24.77 ± 4.53 31.53 ± 3.9 27.79 ± 4.12 1.23 ± 0.13
Underweight (n = 6) 19.27 ± 1.52 27.42 ± 2.23 22.85 ± 2.03 1.16 ± 0.07
Normal weight (n = 26) 23.12 ± 2.74 30.23 ± 1.92 26.22 ± 2.16 1.22 ± 0.11
Overweight (n = 12) 27.35 ± 2.62 32.71 ± 2.37 29.88 ± 2.13 1.2 ± 0.1
Obese (n = 6) 32.22 ± 3.65 38.92 ± 3.89 35.34 ± 2.84 1.39 ± 40.23
BMI body mass index; data as means ± standard deviations of the mean
Underweight referred to BMI < 18.5 kg/m2, normal weight referred to 18.5≤ BMI < 25 kg/m2, overweight referred to 25≤ BMI < 30 kg/m2, obese referred to BMI ≥ 30 kg/m2
Fig. 3 Scatterplots show: volume-computed tomography dose index (CTDIvol) for body mass index (BMI) (a) and effective diameter (b) with correlation
r values of 0.85 and 0.9, respectively; dose length product (DLP) for BMI (c) and effective diameter (d) with r correlation values of 0.84 and 0.89, respectively;
size-specific dose estimate (SSDE) for BMI (e) and effective diameter (f) with r correlation values of 0.87 and 0.88, respectively; effective dose for BMI (g) and
effective diameter (h) with r correlation values of 0.84 and 0.87, respectively
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is calculated as the geometric mean of DAP and DLAT,
as follows:
DE ¼ √ DAP  DLATð Þ
The outer DE (DOUT) equates to the conventional DE
calculated using the AAPM method described above.
The inner DE (DIN) is derived using the anteroposterior
(DAP(IN)) and lateral diameters (DLAT(IN)) measured on
an axial CT image at the midslice level, excluding the
subcutaneous adipose tissue (Fig. 1c). The DIN is then
calculated as the geometric mean of DAP(IN) and
DLAT(IN), as follows:
DIN ¼ √ DAP INð Þ  DLAT INð Þ
 
The DE ratio (DRATIO), another patient size-related
metrics proposed by Lamoureux et al. [7], was also
calculated, as follows:
DRATIO ¼ DOUT=DIN
Statistical analysis
Data were collated using Microsoft Excel 2010 (Microsoft
Corporation, Redmond, WA, USA) and statistical analyses
were conducted by using Microsoft Excel 2010 and
GraphPad Prism version 5.0 (GraphPad Software Inc., San
Diego, CA, USA). Descriptive statistics including means,
standard deviations and ranges were calculated. BMI, dose
indices (CTDIvol, DLP, SSDE, effective dose) and body di-
ameters (DAP, DLAT, DAP+DLAT, DE, DRATIO) were recorded
for each patient CT examination. The correlations
between BMI, dose indices, and body diameter measure-
ments were examined with Pearson correlation analysis
(r). Linear regression models were used to assess the de-
pendence of CTDI, DLP, SSDE, and effective dose on
BMI. Linear regression models were also used to estimate
the relationship of effective diameter (independent vari-
able) with BMI (dependent variable). A p-value lower than
0.05 was taken to indicate statistical significance.
Results
Patient demographics
The study population (n = 50) comprised 19 men and 31
women with an age of 37.9 ± 14.4 years (mean ± standard
deviation [SD], ranging from 17 to 73 years.
BMI and dose metrics
The overall BMI was 24.6 ± 4.8 kg/m2 (mean ± SD), ran-
ging from 17.4 to 38.8 kg/m2. The mean CTDIvol, DLP,
SSDE and effective dose measurements overall, and
when stratified for BMI, are listed in Table 1.
Body diameter measurements
The overall DAP, DLAT, DAP + LAT and DE were 24.8 ±
4.5 cm, 31.5 ± 3.9 cm, 56.3 ± 7.9 cm, and 27.8 ± 4.1 cm
(mean ± SD), respectively. The effective diameter ratio
(DRATIO) was 1.23 ± 0.13 (mean ± SD). The correlations
between BMI and diameter are shown in Fig. 2. Overall,
the best correlation was found with DE (0.88), where
correlations between mean BMI and mean body diame-
ters were highly significant (p < 0.001).
Mean BMI and body diameters across BMI subgroups
are shown in Table 2. Excluding DRATIO, the other body
Fig. 4 Scatterplot of body mass index (BMI) as a function of effective diameter. Linear regression trend line equation: DE = 0.76(BMI) + 9.4
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diameters strongly correlated with each other. The cor-
relation coefficients (r) were 0.78 for DAP − DLAT, 0.96
for DAP − DE, and 0.92 for DLAT − DE, (p < 0.001 for all).
There was a moderate correlation between DLAT and
DRATIO with a correlation coefficient of 0.62 (p < 0.001)
and weak but statistically significant correlations be-
tween DAP and DRATIO (r = 0.34, p = 0.016) and DE and
DRATIO (r = 0.49, p < 0.001). A stronger correlation was
found between DAP + LAT and DE (r = 0.99, p < 0.001) than
with either DAP or DLAT alone and DE [5].
Both BMI and effective body diameter correlated
strongly with all the dose metrics analysed (p < 0.001),
with r values ranging from 0.84 to 0.90. A weaker but
significant correlation of DRATIO with each dose metric
was found: r values ranged from 0.45 to 0.48 (p ≤ 0.05).
These data are summarised in Fig. 3.
The equation of the linear regression trend-line plot-
ting effective diameter as a function of BMI is as follows:
y = 0.76(x) + 9.4 (Fig. 4). Utilising this equation, the pa-
tient’s BMI (x) can be used to calculate an estimate for
the effective diameter (y), i.e. DE = 0.76(BMI) + 9.4.
Table 3 demonstrates a list of conversion factors to cal-
culate SSDE from CTDIvol based on the BMI of the
patient.
Discussion
CTDIvol indicates the amount of radiation delivered by
the scanner for a specific CT examination, calculated on
the basis of a standardised and homogenous phantom
study. It is a precisely defined metrics that is displayed
on the dose protocol of every CT scanner and is a meas-
ure of scanner radiation output, indicating how much
radiation is directed toward the patient rather than
quantifying how much radiation a patient receives [2].
Increasing use of CT and concerns regarding radiation
dose from medical imaging, however, increase the need
for imaging providers to facilitate accurate estimation of
radiation dose to patients.
SSDE is a dose parameter that takes into consideration
corrections based on the size of the patient from linear
dimensions measured on the patient images. SSDE is an
estimate of the mean dose to the centre of the scan vol-
ume for an object having similar attenuation characteris-
tics as a given patient; it is not a direct measurement of
dose to a specific patient [8]. This metrics provides the
ability to estimate the average radiation dose to a patient
in a clinical setting, albeit with 10–20% variability of the
dose estimate from the actual received dose, even when
patient size is taken into account [3]. The AAPM report
[3] recommends that the SSDE for each patient be esti-
mated prior to CT scan using patient size parameters to
best optimise the scanning parameters to achieve the
diagnostic quality CT images with the lowest necessary
radiation dose.
Khawaja et al. [6] demonstrated body weight to be a
more simple and convenient measure than effective diam-
eter to estimate SSDE in paediatric patients at the time of
CT scanning. They argued that measurement of body
diameters in clinical practice is awkward, inconvenient,
Table 3 Conversion factors to convert volume-computed-
tomography dose index (CTDIvol) to size-specific dose estimate
(SSDE) based on body mass index (BMI)
BMI DE CTDIvol/SSDE conversion factor
15 20.8 1.73
16 21.6 1.68
17 22.3 1.63
18 23.1 1.59
19 23.8 1.54
20 24.6 1.50
21 25.4 1.46
22 26.1 1.42
23 26.9 1.38
24 27.6 1.34
25 28.4 1.31
26 29.2 1.27
27 29.9 1.23
28 30.7 1.20
29 31.4 1.17
30 32.2 1.14
31 33.0 1.10
32 33.7 1.07
33 34.5 1.04
34 35.2 1.02
35 36.0 0.99
36 36.8 0.96
37 37.5 0.93
38 38.3 0.91
39 39.0 0.88
40 39.8 0.86
41 40.6 0.84
42 41.3 0.81
43 42.1 0.79
44 42.8 0.77
45 43.6 0.75
46 44.4 0.73
47 45.1 0.71
48 45.9 0.69
49 46.6 0.67
50 47.4 0.65
BMI body mass index, CTDIvol volume-computed-tomography dose index,
DE effective diameter, SSDE size-specific dose estimate
O’Neill et al. European Radiology Experimental            (2018) 2:38 Page 6 of 8
time-consuming and open to interobserver variability,
particularly in the absence of a automated methods of
measurement. An overview of other attempts to estimate
the radiation dose in CT is presented in Table 4 [9–13].
We hypothesised that BMI, being a composite measure-
ment derived from both weight and height, may also rep-
resent an appropriate indicator of patient size to use in
lieu of effective diameter in predicting SSDE. BMI is an
easily, and often routinely, obtained measurement in clin-
ical practice. It is an objective measure with limited bias
or interobserver variability during calculation [14].
The present study assessed relevant size metrics and
demonstrated a very strong correlation between effective
diameter and SSDE (r = 0.88 or 0.87; p < 0.001) with
BMI, indicating that BMI is an accurate alternative to ef-
fective diameter for SSDE estimation in abdominal CT.
Bias from other sources was minimised as all patients
were scanned using a predefined and standardised CT
abdomen and pelvis protocol on a single CT scanner by
one of two radiographers. This paper demonstrates that
effective diameter can be accurately estimated using an
equation and patient BMI. SSDE can then be computed
in a standard manner from CTDIvol by using AAPM
look-up tables to derive conversion factors.
We found that in patients with a wide range of body
habitus measurements (BMI range, 17.4–38.8; effective
diameter range, 19–39.4), BMI measurements correlated
strongly with diameters. The use of BMI to calculate
SSDE has been shown to be a valid alternative to the
traditional methods for manual measurement of
anterior-posterior and lateral-lateral dimensions using
the electronic callipers available on the PACS. A recent
study by Babak Alikhani et al. [15] showed that in
abdominal CT, the size-dependent conversion factor
(f size) closely correlated with patient BMI, indicated
by the exponentially decreasing f size values with in-
creasing BMI. The current study echoes these results
with the proposition that BMI can act as a surrogate
for determining effective body diameter.
The effective diameter ratio (DRATIO) is a new met-
rics proposed by Lamoureux et al. [7] as a supple-
ment to patient-specific size parameter data and is, as
yet, not validated. DRATIO provides information about
anatomical composition, particularly the volume of
extra-abdominal adipose tissue but underestimates
intra-abdominal adiposity. It proved to be a much
weaker predictor of radiation dose to the patient in
terms of CTDIvol, DLP and effective dose than either
effective diameter or BMI (p < 0.001) in the present
paper. Findings suggest that while this metrics is a
good indicator of body fat distribution, it is subopti-
mal as a predictor of patient SSDE.
Table 4 Examples of dose estimation on abdominal computed tomography (CT)
Monte Carlo dose estimation with patient-specific
anatomical models [9]
Full-body computer model created based on the patient’s clinical CT data. Large organs
individually segmented and modelled. Other organs were created by transforming an
existing adult male or female full-body computer model to match the framework defined
by the segmented organs, referencing the organ volume and anthropometry data in ICRP
Publication 89. A Monte Carlo program (General Electric Lightspeed VCT-XTe, GE Healthcare,
GE Medical Systems, Waukesha, WI, USA) was used to estimate patient-specific organ dose,
from which effective dose and risks of cancer incidence were derived. Study suggests the
construction of a large library of patient-specific computer models could estimate dose for
any patient prior to or after a CT examination
Automated measurement of effective diameter [10] Algorithm for estimating body-size diameter on axial CT slice implemented in Python
and C#. Number of pixels whose Hounsfield unit exceeding a set threshold multiplied
by the area of a single pixel to give an estimate of the area of the patient cross-section.
Effective diameter computed as diameter of the circle whose area is the same as that of
the cross-section. Correlation between the manual and automated measurements of
effective diameter was very high
Patient size modelled as a water-equivalent diameter
(DW) [11]
Water-equivalent diameter (DW), automatically extracted from axial CT images and
used to model patient size and subsequently to calculate size-specific dose estimates.
The extracted DW values correlate well with effective diameter (R
2 of 0.90 for abdomen
and pelvis)
Dose estimation through directly using
thermoluminescent dosemeters (TLDs) [12]
Thermoluminescent dosemeters (TLDs) and a Rando Alderson phantom used. Computer-
simulated dose estimation based on National Radiation Protection Board Monte Carlo
simulations. Directly measured dose 18% higher than computer-simulated dosimetry,
suggesting underestimation by computer-simulation techniques compared with TLD
measurements
Topogram-based body size indices for CT dose
consideration and scan protocol optimisation [13]
Linear regression of four topographical indices for estimation of Dw (i) average diameter;
(ii) girth (cross-section modelled as ellipse); (iii) topogram projection area; (iv) improved
topogram projection area (corrected for patient miscentering and water attenuation
coefficient)
Correlating body weight with diameter for radiation
dose estimates [6]
Anteroposterior and lateral diameters were measured manually and through automated
software. Effective diameter subsequently calculated. Overall body weight had a strong
correlation with diameter
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Our study has some limitations. Our sample size is
relatively low (n = 50), with patients chosen because
standardised CT imaging on this well-characterised co-
hort had already been performed and BMI measure-
ments were available for all of them; CT images and
data were readily available to test this hypothesis without
the need to image further patients. A larger sample size
may strengthen the assessment of the relationship be-
tween effective diameter and BMI. In addition, with a
larger sample size, it could be possible to estimate trend
lines stratified for BMI, which may lead to better esti-
mates of diameter and hence of SSDE.
Due to the retrospective design of this study, BMI
measurements only were available rather than the con-
stituent height and weights. Statistical evaluation of the
interplay of these parameters with BMI, body diameters
and radiation dose may have yielded further supportive
information. With the advent of automated body diam-
eter and SSDE measurement technology, the applicabil-
ity of our findings may not be relevant to the small
proportion of centres that possess these technologies.
Dose optimisation is a key factor to current radiology
practice, particularly for CT when the correct balance
between radiation dose and image quality needs to be
struck. To be useful and effective, any applied method of
estimating patient radiation dose needs to be user-
friendly and reproducible. The present paper indicates
that patient BMI can be used to accurately estimate ef-
fective diameter, obviating the need to measure antero-
posterior and lateral diameters in order to calculate
SSDE at the time of CT.
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